NGL Fine-Chem Ltd (NGLFINE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524774 | NSE: NGLFINE | Pharmaceuticals & Drugs | Small Cap

NGL Fine-Chem Share Price

1,313 11.95 0.92%
as on 05-Dec'25 12:00

NGL Fine-Chem Ltd (NGLFINE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524774 | NSE: NGLFINE | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on NGL Fine-Chem

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

NGL Fine-Chem stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
50.86
Market Cap:
803.8 Cr.
52-wk low:
962.7
52-wk high:
2,161

Is NGL Fine-Chem Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of NGL Fine-Chem: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
NGL Fine-Chem Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 37.1%33.8%21.7%27.6%13.7%51.9%34.7%11.5%18.9%8.3%-
Value Creation
Index
1.71.40.61.00.02.71.5-0.20.4-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 96.399.7114153152258319275329359398
Sales YoY Gr.-3.6%14%34.8%-0.7%69.7%23.4%-13.7%19.6%9.2%-
Adj EPS 18.522.918.62916.688.184.629.458.426.225.6
YoY Gr.-24.2%-18.9%56%-42.7%430%-4%-65.2%98.4%-55.2%-
BVPS (₹) 71.696.2116.6149.1163.8251.6334.4365425.4452.6475.8
Adj Net
Profit
11.414.211.517.910.354.552.318.236.116.216
Cash Flow from Ops. 8.49.922.48.919.626.615.831.911.117-
Debt/CF from Ops. 1.72.31.23.11.40.61.913.14.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 15.8%18.8%4.1%9.2%
Adj EPS 4%9.5%-32.4%-55.2%
BVPS22.7%22.5%10.6%6.4%
Share Price 14.2% 1.2% -7.5% -29.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
29.627.317.521.810.642.428.98.414.865.5
Op. Profit
Mgn %
22.825.61921.115.229.820.710.413.67.47.3
Net Profit
Mgn %
11.814.210.111.76.821.116.46.6114.54
Debt to
Equity
0.30.40.40.30.30.10.20.10.10.30.1
Working Cap
Days
160187198167184132166216186191106
Cash Conv.
Cycle
7481655579497499767352

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - NGL Fine-Chem Ltd.

Standalone Consolidated
TTM EPS (₹) 25.6 33.5
TTM Sales (₹ Cr.) 398 409
BVPS (₹.) 475.8 485.9
Reserves (₹ Cr.) 291 297
P/BV 2.73 2.68
PE 50.86 38.85
From the Market
52 Week Low / High (₹) 962.70 / 2161.00
All Time Low / High (₹) 0.40 / 3789.45
Market Cap (₹ Cr.) 804
Equity (₹ Cr.) 3.1
Face Value (₹) 5
Industry PE 40.7

Management X-Ray of NGL Fine-Chem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of NGL Fine-Chem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of NGL Fine-Chem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales96100114153152258319275329359
Operating Expenses 747492121131181253246284333
Manufacturing Costs13151822273350506369
Material Costs4138466365103148140155185
Employee Cost 11141821242733344151
Other Costs 1081015161922232528
Operating Profit 22252232217766294527
Operating Profit Margin (%) 22.8%25.5%19.0%21.1%13.7%29.8%20.7%10.4%13.6%7.4%
Other Income 0134391381610
Interest 2123322223
Depreciation 3356778889
Exceptional Items 0000000000
Profit Before Tax 18231828147669275124
Tax 6857421176126
Profit After Tax 11151320115552203918
PAT Margin (%) 11.8%14.9%11.1%13.1%7.0%21.5%16.4%7.3%11.7%5.0%
Adjusted EPS (₹)18.524.120.532.617.289.884.632.662.429.4
Dividend Payout Ratio (%)0%0%0%5%10%2%2%5%3%6%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 44597292101155207226263280
Share Capital 3333333333
Reserves 4156698998152203222260277
Minority Interest0000000000
Debt13202423231127303272
Long Term Debt091288632125
Short Term Debt1211111515523283247
Trade Payables14142416212735234754
Others Liabilities 717141811121091120
Total Liabilities 78111133149156206278288353426

Fixed Assets

Gross Block38286474818592100108177
Accumulated Depreciation133713202733414857
Net Fixed Assets 242556616158595960120
CWIP 21630016264650
Investments 3669143332435763
Inventories10121719283855274349
Trade Receivables32302833263865658380
Cash Equivalents 22433511326
Others Assets 4201925233460546358
Total Assets 78111133149156206278288353426

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 810229202716321117
PBT 18231828147669275124
Adjustment 335811376-19
Changes in Working Capital -6-84-19-2-32-436-26-10
Tax Paid -6-8-5-7-4-21-17-6-12-6
Cash Flow From Investing Activity -10-10-21-10-19-24-16-24-17-16
Capex -10-18-23-14-7-5-14-29-28-73
Net Investments 0100-410000
Others 0725-8-20-251157
Cash Flow From Financing Activity 2000-1-1-1-1-1-1
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -1000000000
Interest Paid 0000000000
Dividend Paid 0000-1-1-1-1-1-1
Others 3000000000
Net Cash Flow 0-01-1-02-17-70

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)29.5928.7319.2224.5210.9743.2228.869.3115.786.69
ROCE (%)37.1433.821.6827.6313.6551.934.7111.518.938.29
Asset Turnover Ratio1.441.130.951.0811.431.320.971.030.92
PAT to CFO Conversion(x)0.730.671.690.451.820.490.311.60.280.94
Working Capital Days
Receivable Days1031079172714559868283
Inventory Days39374542564653543947
Payable Days1231231451119774657183100

NGL Fine-Chem Ltd Stock News

NGL Fine-Chem Ltd FAQs

The current trading price of NGL Fine-Chem on 05-Dec-2025 12:00 is ₹1,313.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of NGL Fine-Chem stood at ₹803.8.
The latest P/E ratio of NGL Fine-Chem as of 04-Dec-2025 is 50.86.
The latest P/B ratio of NGL Fine-Chem as of 04-Dec-2025 is 2.73.
The 52-week high of NGL Fine-Chem is ₹2,161 and the 52-week low is ₹962.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of NGL Fine-Chem is ₹397.6 ( Cr.) .

About NGL Fine-Chem Ltd

NGL Fine-chem  is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.

Utilizing its expertise in complex multi-stage organic synthesis, it continues to expand the product portfolio with new products.

It has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant technological upgradation.

NGL Fine-chem Ltd has a strong focus on developing intellectual property as a key differentiator and as a platform for further growth up the pharma value chain. It respect intellectual property and invest in developing it as a key growth driver for the future.

Product range of the company includes:

Pharmaceutical like Diminazene Aceturate, Diminazene Diaceturate, Homidium Chloride, Nitroxynil, Clorsulon, Homidium Bromide, Parvaquone, Carprofen, Buparvaquone and Isometamidium Chloride Hydrochloride for:

  • Animal health
  • Human health
  • Intermediate- 4 Aminobenzamidine Dihydrochloride, 3 Aminobenzamidine Dihydrochloride, Ezetimibe Intermediates etc
  • Finished dosages form- Homidium Chloride Tablets, Diminazene Aceturate Granules

Achievements/ recognition

An ISO 9001:2000 accredited company

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×